A78.full
Loading viewer...
report
Format: PDF report
This report evaluates the efficacy of NKX019, a CD19-targeting CAR NK cell therapy, showcasing its potential in treating B-ALL with enhanced cytolytic activity.
Loading viewer...
report
Format: PDF report
This report evaluates the efficacy of NKX019, a CD19-targeting CAR NK cell therapy, showcasing its potential in treating B-ALL with enhanced cytolytic activity.
report
Guavus
report
Berg Insight
report
Bristol Myers Squibb
report
NetIQ
